Dianthus Therapeutics Inc (DNTH)

Finanzdaten der Dianthus Therapeutics Inc-Aktie (DNTH)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	32.44%62.24	47.00	69.83	40.68	35.12
Research and Development	41.00%48.69	34.53	59.90	32.49	26.25
Operating Income/Loss	32.13%-61.48	-46.53	-69.54	-40.29	-34.93
Nonoperating Income/Loss	97.70%11.27	5.70	5.11	3.52	3.30
	22.97%-50.22	-40.83	-64.43	-36.77	-31.63
Attributable To Parent	22.97%-50.22	-40.83	-64.43	-36.77	-31.63
Basic Average Shares	16.65%56.03	48.03	2.14	37.79	35.82
Diluted Average Shares	16.65%56.03	48.03	2.14	37.79	35.82
Basic Earnings Per Share	5.88%-0.90	-0.85	-1.52	-0.97	-0.88
Diluted Earnings Per Share	5.88%-0.90	-0.85	-1.52	-0.97	-0.88
Common Stock Dividends	-	-	-	-	-